Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Clinical Investigation

• Publication date

  1987-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI112902PMID 3102560PMCID PMC424237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of fibrin monomer and an in vivo thrombin-induced-anticoagulant in experimental venous thrombosis.

  2009cited by this paper
• Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

  1986cited by this paper
• Activation of coagulation releases endothelial cell mitogens

  1986cited by this paper
• Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va.

  1986cited by this paper
• Protein S is required for bovine platelets to support activated protein C binding and activity.

  1985cited by this paper
• Whole blood clot lysis: in vitro modulation by activated protein C.

  1985cited by this paper
• Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

  1985cited by this paper
• Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia.

  1984cited by this paper
• A model for thrombin protection against endotoxin.

  1984cited by this paper
• Detection of the 'hyperdynamic state' of sepsis in the baboon during lethal E. coli infusion.

  1983cited by this paper
• Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.

  1982cited by this paper
• Bleeding disorders : investigation and management

  1982cited by this paper
• Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme.

  1982cited by this paper
• Activation of protein C in vivo.

  1982cited by this paper
• Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.

  1982cited by this paper
• Deficiencies of protein C, an inhibitor of blood coagulation.

  1982cited by this paper
• Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

  1981cited by this paper
• Generation of fibrinolytic activity by infusion of activated protein C into dogs.

  1981cited by this paper
• Preparation and properties of bovine factor VIII (antihemophilic factor).

  1980cited by this paper
• The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

  1979influential reference
• A pathologic study of Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment.

  1978cited by this paper
• Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

  1978cited by this paper
• Proteolytic activation of protein C from bovine plasma.

  1976cited by this paper
• The Fundamental Mechanisms of Shock

  1972cited by this paper
• Fibrinogen degradation products.

  1971cited by this paper
• Disseminated intravascular coagulation : an intermediary mechanism of disease

  1965cited by this paper
• Serum Glutamic Pyruvic Transaminase in Cardiac and Hepatic Disease.∗

  1956cited by this paper
• [The reaction of factor V in the serum under normal and pathological conditions].

  1955cited by this paper

• A central role of factor XI in a baboon model of Staphylococcus aureus sepsis.

  2025cites this paper
• The convergent model of coagulation.

  2024cites this paper
• Immunity and Coagulation in COVID-19

  2024cites this paper
• Safety and efficacy of anti-human activated protein C antibody SR604 for prophylaxis of congenital factor deficiencies.

  2023cites this paper
• Thrombin in complex with dabigatran can still interact with PAR‐1 via exosite‐I and instigate loss of vascular integrity

  2022cites this paper
• Protein C Pathway in Paediatric and Neonatal Sepsis

  2022cites this paper
• Fibrin structure, viscoelasticity and lysis face the interplay of biorelevant polyions

  2022cites this paper
• Inflammation, Coagulation Process in Sepsis and LMWH Role in it

  2022cites this paper
• Old drug, new Trick? The rationale for the treatment of COVID-19 with activated protein C

  2021cites this paper
• Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy

  2021cites this paper
• Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis

  2020cites this paper
• Protein C

  2020cites this paper
• Molecular basis of protease‐activated receptor 1 signaling diversity

  2020cites this paper
• Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis

  2020cites this paper
• Crosstalk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation

  2019cites this paper
• Stillbirth and factor V Leiden - A regional based prospective evaluation.

  2019cites this paper
• Nonhuman primate species as models of human bacterial sepsis

  2019cites this paper
• Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39

  2019cites this paper
• Re-Evaluating Biologic Pharmacotherapies That Target the Host Response during Sepsis

  2019cites this paper
• Inflammatory Wnt5A signaling in macrophages as novel target for anti-inflammatory action of activated protein C

  2019cites this paper
• Deciphering the Role of WNT Signaling in Metabolic Syndrome–Linked Alzheimer’s Disease

  2019cites this paper
• Distinct from Known Ligands

  2018cites this paper
• Effets anti-inflammatoires de l'inhibiteur dépendant de la protéine Z : intérêt potentiel comme traitement adjuvant du sepsis. (Anti-inflammatory effects of Protein Z-dependent protease inhibitor (ZPI) : potential benefit on sepsis adjuvant therapy)

  2018cites this paper
• Activated protein C, protease activated receptor 1, and neuroprotection.

  2018cites this paper
• Exploring traditional and nontraditional roles for thrombomodulin.

  2018cites this paper
• Synergistic Cofoctor Function of Foclor V ond Prolein S to Aclivoled Protein C in the lnoclivotion of the Foctor Vlllo - Foclor lXo Complex Species Specific lnleroctions of Components of the Prolein C Anlicoogulont System

  2018cites this paper
• Coagulopathies and inflammatory diseases: '…glimpse of a Snark'.

  2018cites this paper
• SepticShock,MultipleOrganFailure,and Disseminated Intravascular Coagulation* ComparedPatternsof Antithrombin III, ProteinC, andProteinS Deficiencies

  2017cites this paper
• Molecular Targets for Therapy

  2017cites this paper
• Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation.

  2017cites this paper
• Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.

  2017cites this paper
• Thrombin contributes to protective immunity in pneumonia‐derived sepsis via fibrin polymerization and platelet–neutrophil interactions

  2017cites this paper
• Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis.

  2017cites this paper
• Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo

  2017cites this paper
• Akciğer Fibrozisi Oluşturulmuş Ratlarda Elektrolit Düzeylerinin Araştırılması

  2017cites this paper
• Multiple receptor-mediated functions of activated protein

  2017cites this paper
• Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis

  2017cites this paper
• Bridging the Translational Gap: The Challenges of Novel Drug Development in Critical Care

  2017cites this paper
• Hemostatic abnormalities in dogs with naturally occurring heatstroke

  2017cites this paper
• A case report of septic shock syndrome caused by S. pneumoniae in an immunocompromised patient despite of vaccination

  2017cites this paper
• The Immunoregulatory Activities of Activated Protein C in Inflammatory Disease

  2017cites this paper
• Activated Protein C

  2016cites this paper
• Differential Paradigms in Animal Models of Sepsis

  2016cites this paper
• Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases

  2016cites this paper
• Innate immunity, hemostasis and matrix remodeling: PTX3 as a link.

  2016cites this paper
• Prednizolon ile Karşılaştırılması Effects of Recombinant Activated Protein C Derived From Drotrecogin-Alpha on Bleomycin-Induced Pulmonary Fibrosis in Rats Compared with MethylPrednisolone

  2016cites this paper
• 3K3A–activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice

  2016cites this paper
• Einfluss von doppelsträngiger RNA auf die Thrombusbildung in der Mikrozirkulation der Maus

  2016cites this paper
• Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.

  2016cites this paper
• Circulating Histones and Nucleosomes as Biomarkers in Sepsis and Septic Shock

  2016cites this paper
• Neutrophil-Mediated Vascular Host Defense

  2016cites this paper
• Tratamie nto de la co agulo patía e n la s e ps is s e ve ra

  2016cites this paper
• Low‐grade endotoxemia and clotting activation in the early phase of pneumonia

  2016cites this paper
• Evaluation d'un variant d'antithrombine dans différentes indications thérapeutiques

  2016cites this paper
• Activated protein C: biased for translation.

  2015cites this paper
• Metabolic shifts during aging and pathology.

  2015cites this paper
• Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury.

  2015cites this paper
• clinical investigations in critical care

  2015cites this paper
• Endothelial barrier dysfunction in septic shock

  2015cites this paper
• Organ Dysfunction Following Trauma, Shock and Sepsis: An Update

  2015cites this paper
• Part I : Biochemistry, Assay, and Possible Role in Diverse Disease States

  2015cites this paper
• On the evolutionary advantage of coagulation factor V Leiden (FVL).

  2015cites this paper
• Lack of Association Between Factor V Leiden and Sepsis

  2015cites this paper
• Elevated soluble endothelial protein C receptor levels at ICU admission are associated with sepsis development.

  2015cites this paper
• The role of platelets in sepsis

  2015cites this paper
• ResearchActivated protein C ameliorates coagulopathy but does not influence outcome in lethal H 1 N 1 influenza : a controlled laboratory study

  2015cites this paper
• Chapter 104 – Hypercoagulable States

  2015cites this paper
• Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar.

  2015cites this paper
• Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect

  2015cites this paper
• THROMBOSIS AND HEMOSTASIS Activated protein C b-glycoform promotes enhanced noncanonical PAR 1 proteolysis and superior resistance to ischemic injury

  2015cites this paper
• Activated Protein C Ameliorates Renal Ischemia-Reperfusion Injury by Restricting Y-Box Binding Protein-1 Ubiquitination.

  2015cites this paper
• Engineering activated protein C to maximize therapeutic efficacy.

  2015cites this paper
• Effect of Intra-Cuff Tetracaine on Preventing Postoperative Sore Throat after Gynecological Surgery

  2015cites this paper
• Regulation of Endothelial Cell Inflammation and Lung Polymorphonuclear Lymphocyte Infiltration by Transglutaminase 2

  2014cites this paper
• Effects of Exogenous Recombinant APC in Mouse Models of Ischemia Reperfusion Injury and of Atherosclerosis

  2014cites this paper
• Evidence-Based Intensive Care

  2014cites this paper
• New therapeutic options for patients with sepsis and disseminated intravascular coagulation.

  2014cites this paper
• Gain in translation: heme oxygenase‐1 induced by activated protein C promotes thrombus resolution

  2014cites this paper
• Evaluation of Hemostasis

  2014cites this paper
• A Short Contemporary History of Disseminated Intravascular Coagulation

  2014cites this paper
• Therapeutic strategies for the protection of renal oxygenation in experimental models of acute kidney injury

  2014cites this paper
• Augmenting the protein C pathway with endothelial targeted biotherapeutics: Strategies to promote partnering of TM and EPCR

  2014cites this paper
• A 61-year-old man with disseminated intravascular coagulation: a case report.

  2014cites this paper
• The protein C system in severe infection

  2014cites this paper
• Investigation of vascular dysfunction in pre-clinical models of sepsis

  2014cites this paper
• The coagulation system and its function in early immune defense

  2014cites this paper
• Investigating the effects of Yersinia pestis V antigen as an immunomodulator of innate immune responses in sepsis

  2014cites this paper
• Strategies to improve drug development for sepsis

  2014cites this paper
• Activated protein C and its potential applications in prevention of islet β-cell damage and diabetes.

  2014cites this paper
• Targeting factor Xa and thrombin: impact on coagulation and beyond

  2013cites this paper
• Replacement of specific coagulation factors in patients with burn: a review.

  2013cites this paper
• Intraperitoneal administration of activated protein C prevents postsurgical adhesion band formation.

  2013cites this paper
• Evolution of Factor V Leiden

  2013cites this paper
• Streptococcal SpeB Cleaved PAR-1 Suppresses ERK Phosphorylation and Blunts Thrombin-Induced Platelet Aggregation

  2013cites this paper
• Activated Protein C Improves Macrovascular and Microvascular Reactivity in Human Severe Sepsis and Septic Shock

  2013cites this paper
• R268A, inhibits thrombosis in a model of acute carotid artery injury A recombinant murine meizothrombin precursor, prothrombin R157A/

  2013cites this paper
• Mac-1 Directly Binds to the Endothelial Protein C-Receptor: A Link between the Protein C Anticoagulant Pathway and Inflammation?

  2013cites this paper
• Plasma Bacterial and Mitochondrial DNA Distinguish Bacterial Sepsis From Sterile Systemic Inflammatory Response Syndrome and Quantify Inflammatory Tissue Injury in Nonhuman Primates

  2013cites this paper
• Endothelial protein C receptor polymorphisms and risk of severe sepsis in critically ill patients

  2013cites this paper
• Sepsis and Thrombosis

  2013cites this paper